Search Results 2321-2330 of 17357 for Selective mutism
TP-0903 is a novel oral inhibitor that targets AXL kinase. Preclinical studies have shown promising antitumor activity of TP-0903 as a single agent against a ...
About this study. The potential role of Small bowel bacterial overgrowth (SBBO) in weight loss occurring in patients with PD has not previously been ...
About this study. RATIONALE: Collecting and storing samples of tissue from patients with cancer to test in the laboratory may help the study of cancer in ...
The purpose of this study is to evaluate the custom made Stealth Arc Delivery device versus a commercially available device to improve the precision, efficiency ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. IgG4-related disease is a recently recognized disease that can mimic other diseases and that can be difficult to diagnose.
5 will be assessed by measuring the extent of tumor shrinkage. SC16LD6.5 is an antibody-drug conjugate (ADC). The antibody (SC16) targets a protein that appears ...
The purpose of this study is to characterize ultrasound vibro-elastography features of ocular tumors. Participation eligibility. Participant eligibility ...
This registry should advance knowledge in the field both from a molecular (genomic and proteomic) and from a clinical phenotype standpoint. Participation ...
About this study. Primary Aims. In tissue, to discover and validate DNA methylation markers (MDMs) for detection of malignant renal and urothelial tumors.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!